Fedha

Hisa unazofuatilia
ABVX:EPA
Abivax SA
€ 77.15
-0.64%
(-0.50) Siku 1
6 Nov, 17:36:06 GMT +1  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya ABVX...
Fungua
€ 74.45
Juu
€ 77.15
Chini
€ 73.80
Mtaji wa soko
6.84B
Wastani wa kiasi cha mauzo
elfu 111.44
Kiasi cha mauzo ya hisa
elfu 161.37
Juu kwa wiki 52
€ 139.00
Chini kwa wiki 52
€ 60.45
EPS
-€ 5.20
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Fungua
€ 74.45
Juu
€ 77.15
Chini
€ 73.80
Mtaji wa soko
6.84B
Wastani wa kiasi cha mauzo
elfu 111.44
Kiasi cha mauzo ya hisa
elfu 161.37
Juu kwa wiki 52
€ 139.00
Chini kwa wiki 52
€ 60.45
EPS
-€ 5.20
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Kuhusu Abivax SA
Afisa Mkuu Mtendaji (CEO)Marc de Garidel | Hartmut J. Ehrlich
Wafanyakazi98
Lilianzishwa4 Des 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutiabivax.com
Ripoti ya mwisho
21 Sep 2026
Kipindi cha Kifedha
Robo2 2026
- / -€ 0.61
Mapato dhidi ya makadirio (EUR)
elfu 976.00 / elfu 814.89
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika EUR
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika EUR
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
elfu 639.00
1.91M
1.34M
elfu 976.00
Gharama ya bidhaa zilizouzwa
-
-
-
-
Gharama ya mapato
-
-
-
-
Gharama za utafiti na maendeleo
55.42M
44.40M
49.54M
58.34M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
27.34M
27.69M
8.03M
26.98M
Gharama ya uendeshaji
81.35M
73.56M
57.57M
85.09M
Jumla ya gharama za uendeshaji
81.35M
73.56M
57.57M
85.09M
Mapato ya uendeshaji
-80.71M
-71.65M
-56.23M
-84.11M
Mapato mengine yasiyo ya uendeshaji
-74.20M
-4.96M
elfu 119.00
4.72M
EBT ikijumuisha vipengee visivyo vya kawaida
-153.36M
-76.11M
-48.24M
-123.51M
EBT bila kujumuisha vipengee visivyo vya kawaida
-153.36M
-80.84M
-51.51M
-80.30M
Gharama ya kodi ya mapato
-
5.85M
elfu 228.00
-6.08M
Kiwango cha kodi kinachotumika
-
-7.68%
-0.47%
4.92%
Gharama nyingine za uendeshaji
-1.40M
1.47M
-
elfu -225.00
Mapato halisi
-153.36M
-81.96M
-48.47M
-117.43M
Kiwango cha faida halisi
-23,999.69%
-4,282.13%
-3,606.25%
-12,032.07%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
3.36M
1.19M
elfu 644.00
-
Gharama ya riba
-4.21M
-15.27M
-2.54M
elfu -730.00
Jumla ya gharama halisi za riba
elfu -852.00
-14.08M
-1.90M
elfu -730.00
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-80.63M
-70.76M
-56.14M
-84.02M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Matukio yajayo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google